BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 17875550)

  • 1. The MHC2TA -168A/G polymorphism and risk for rheumatoid arthritis: a meta-analysis of 6861 patients and 9270 controls reveals no evidence for association.
    Bronson PG; Criswell LA; Barcellos LF
    Ann Rheum Dis; 2008 Jul; 67(7):933-6. PubMed ID: 17875550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The MHC2TA -168A>G gene polymorphism is not associated with rheumatoid arthritis in Austrian patients.
    Yazdani-Biuki B; Brickmann K; Wohlfahrt K; Mueller T; März W; Renner W; Gutjahr M; Langsenlehner U; Krippl P; Wascher TC; Paulweber B; Graninger W; Brezinschek HP
    Arthritis Res Ther; 2006; 8(4):R97. PubMed ID: 16776848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the MHC2TA gene in autoimmune diseases.
    Martínez A; Sánchez-Lopez M; Varadé J; Mas A; Martín MC; de Las Heras V; Arroyo R; Mendoza JL; Díaz-Rubio M; Fernández-Gutiérrez B; de la Concha EG; Urcelay E
    Ann Rheum Dis; 2007 Mar; 66(3):325-9. PubMed ID: 17012290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between the functional MHC2TA -168 A/G polymorphism and susceptibility to rheumatoid arthritis: a meta-analysis.
    Lee YH; Bae SC
    Clin Rheumatol; 2016 Apr; 35(4):901-9. PubMed ID: 26439834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MHC2TA promoter polymorphism (-168*G/A, rs3087456) is not associated with susceptibility to rheumatoid arthritis in British Caucasian rheumatoid arthritis patients.
    Harrison P; Pointon JJ; Farrar C; Harin A; Wordsworth BP
    Rheumatology (Oxford); 2007 Mar; 46(3):409-11. PubMed ID: 16920747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction.
    Swanberg M; Lidman O; Padyukov L; Eriksson P; Akesson E; Jagodic M; Lobell A; Khademi M; Börjesson O; Lindgren CM; Lundman P; Brookes AJ; Kere J; Luthman H; Alfredsson L; Hillert J; Klareskog L; Hamsten A; Piehl F; Olsson T
    Nat Genet; 2005 May; 37(5):486-94. PubMed ID: 15821736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MHC2TA single nucleotide polymorphism and genetic risk for autoimmune adrenal insufficiency.
    Ghaderi M; Gambelunghe G; Tortoioli C; Brozzetti A; Jatta K; Gharizadeh B; De Bellis A; Pecori Giraldi F; Terzolo M; Betterle C; Falorni A
    J Clin Endocrinol Metab; 2006 Oct; 91(10):4107-11. PubMed ID: 16849401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter polymorphism rs3087456 in the MHC class II transactivator gene is not associated with susceptibility for selected autoimmune diseases in German patient groups.
    Akkad DA; Jagiello P; Szyld P; Goedde R; Wieczorek S; Gross WL; Epplen JT
    Int J Immunogenet; 2006 Feb; 33(1):59-61. PubMed ID: 16426246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of the MHC2TA gene, associated with rheumatoid arthritis in a Swedish population, in a UK rheumatoid arthritis cohort.
    Eyre S; Bowes J; Spreckley K; Potter C; Ring S; Strachan D; Worthington J; Barton A
    Arthritis Rheum; 2006 Nov; 54(11):3417-22. PubMed ID: 17075826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphism in MHC class II transactivator gene is not associated with susceptibility to colorectal cancer in Swedish patients.
    Mumtaz M; Löfgren S; Hugander A; Dimberg J
    Anticancer Res; 2008; 28(3B):1789-91. PubMed ID: 18630461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MHC2TA and FCRL3 genes are not associated with rheumatoid arthritis in Mexican patients.
    Mendoza Rincón JF; Rodríguez Elias AK; Fragoso JM; Vargas Alarcón G; Maldonado Murillo K; Rivas Jiménez ML; Barbosa Cobos RE; Jimenez Morales S; Lugo Zamudio G; Tovilla Zárate C; Ramírez Bello J
    Rheumatol Int; 2016 Feb; 36(2):249-54. PubMed ID: 26350270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CIITA gene polymorphism (rs3087456) in systemic lupus erythematosus and rheumatoid arthritis: A population-based cohort study.
    Lima SC; Gomes da Silva IIF; Nascimento DQ; de Moura RR; Mesquita MDS; Asano NMJ; Fernandes GV; Valente LM; Rushansky E; Mariano MHQA; Xavier RM; Chies JAB; Crovella S; Sandrin-Garcia P
    Int J Immunogenet; 2021 Oct; 48(5):429-434. PubMed ID: 34180145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The MHC2TA-168A/G and +1614G/C polymorphisms and risk for multiple sclerosis or chronic inflammatory arthropathies.
    O'Doherty C; Hawkins S; Rooney M; Vandenbroeck K
    Tissue Antigens; 2007 Sep; 70(3):247-51. PubMed ID: 17661914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A polymorphic variant in the MHC2TA gene is not associated with systemic lupus erythematosus.
    Linga-Reddy MV; Gunnarsson I; Svenungsson E; Sturfelt G; Jönsen A; Truedsson L; Nordmark G; Rönnblom L; Alarcón-Riquelme ME
    Tissue Antigens; 2007 Nov; 70(5):412-4. PubMed ID: 17711409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Major histocompatibility complex class II transactivator gene polymorphism: associations with Löfgren's syndrome.
    Grunewald J; Idali F; Kockum I; Seddighzadeh M; Nisell M; Eklund A; Padyukov L
    Tissue Antigens; 2010 Aug; 76(2):96-101. PubMed ID: 20230522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of MHCIITA rs3087456 and rs4774 polymorphisms in the susceptibility to cardiovascular disease of patients with rheumatoid arthritis.
    Garcia-Bermudez M; González-Juanatey C; Lopez-Mejias R; Rodriguez-Rodriguez L; Pérez-Esteban S; Castañeda S; Urcelay E; Miranda-Filloy JA; Gómez-Vaquero C; Fernández-Gutierrez B; Balsa A; González-Alvaro I; Blanco R; Llorca J; Martín J; Gonzalez-Gay MA
    Clin Exp Rheumatol; 2012; 30(1):51-7. PubMed ID: 22272574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of association with rheumatoid arthritis of selected polymorphisms in 4 candidate genes: CFH, CD209, eotaxin-3, and MHC2TA.
    Dieguez-Gonzalez R; Akar S; Calaza M; Gonzalez-Alvaro I; Fernandez-Gutierrez B; Lamas JR; de la Serna AR; Caliz R; Blanco FJ; Pascual-Salcedo D; Velloso ML; Perez-Pampin E; Pablos JL; Navarro F; Narvaez J; Lopez-Longo FJ; Herrero-Beaumont G; Gomez-Reino JJ; Gonzalez A
    J Rheumatol; 2009 Aug; 36(8):1590-5. PubMed ID: 19567623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic modulation of RFC1, MHC2TA and HLA-DR in systemic lupus erythematosus: association with serological markers and six functional polymorphisms of one-carbon metabolic pathway.
    Rupasree Y; Naushad SM; Rajasekhar L; Kutala VK
    Gene; 2014 Feb; 536(1):45-52. PubMed ID: 24333266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphism in the MHC2TA gene is associated with features of the metabolic syndrome and cardiovascular mortality.
    Lindholm E; Melander O; Almgren P; Berglund G; Agardh CD; Groop L; Orho-Melander M
    PLoS One; 2006 Dec; 1(1):e64. PubMed ID: 17183695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The variant rs8048002 T>C in intron 3 of the MHC2TA gene is associated with risk of developing acute coronary syndrome.
    Vargas-Alarcón G; Posadas-Romero C; Posadas-Sánchez R; Martínez-Alvarado R; González-Pacheco H; Martínez-Sánchez C; Martínez-Ríos MA; Juarez-Cedillo T; Ramirez-Fuentes S; Pérez-Méndez O; Fragoso JM
    Cytokine; 2015 Feb; 71(2):268-71. PubMed ID: 25461408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.